Abstract
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biomedical Research / economics
-
Biomedical Research / methods*
-
Biomedical Research / trends
-
Clinical Trials as Topic*
-
Cooperative Behavior
-
Drug Discovery / economics
-
Drug Discovery / organization & administration*
-
Drug Discovery / standards
-
Drug Discovery / trends
-
Drug Evaluation / economics
-
Drug Evaluation / methods*
-
Drug Evaluation / trends
-
Drug Industry / economics
-
Drug Industry / methods*
-
Drug Industry / trends
-
Humans
-
Molecular Probes / chemistry*